DSM Executive Committee members purchase DSM shares

Royal DSM, the global science-based company active in health, nutrition and materials, announces that all members of its Executive Committee purchase ordinary shares in Royal DSM, expressing their confidence in the growth prospects of the company.

All eight members of the DSM Executive Committee have decided to purchase ordinary shares in Royal DSM, partly by own investments and partly by converting a part of their Short Term Incentive cash into shares. The total amount is approximately 35,000 shares, representing circa €200,000 cash per individual. Details of the transactions are provided in the notification to the Autoriteit Financiële Markten (AFM), according to the applicable regulations.

In addition, the members of the Executive Committee who had options that expire in March 2016, exercised these vested stock incentives which were granted in 2008.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

For more information: